title: An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
abstract: Experimental autoimmune encephalomyelitis (EAE) is a CD4+ T cell-mediated, inflammatory demyelinating disease of the central nervous system (CNS) that serves as a model for the human demyelinating disease, multiple sclerosis. A critical event in the pathogenesis of EAE is the entry of both Ag-specific T lymphocytes and Ag-nonspecific mononuclear cells into the CNS. In the present report we investigated the role of two C-C chemokines (macrophage inflammatory protein-1 alpha (MIP-1 alpha) and monocyte chemotactic protein-1) and a C-x-C chemokine (MIP-2) in the pathogenesis of EAE. Production in the CNS of MIP-1 alpha, but not that of MIP-2, a rodent homologue of IL-8, or monocyte chemotactic protein-1, correlated with development of severe clinical disease. Administration of anti-MIP-1 alpha, but not that of anti-monocyte chemotactic protein-1, prevented the development of both acute and relapsing paralytic disease as well as infiltration of mononuclear cells into the CNS initiated by the transfer of neuroantigen peptide-activated T cells. Ab therapy could also be used to ameliorate the severity of ongoing clinical disease. Anti-MIP-1 alpha did not affect the activation of encepahlitogenic T cells as measured by cytokine secretion, surface marker expression, and ability to adoptively transfer EAE. These results demonstrate that MIP-1 alpha plays an important role in directing the chemoattraction of mononuclear inflammatory cells in the T cell-mediated autoimmune disease, EAE.
authors.affiliation: Department of Microbiology and Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.
authors.forename: W J
authors.initials: WJ
authors.lastname: Karpus
authors.forename: N W
authors.initials: NW
authors.lastname: Lukacs
authors.forename: B L
authors.initials: BL
authors.lastname: McRae
authors.forename: R M
authors.initials: RM
authors.lastname: Strieter
authors.forename: S L
authors.initials: SL
authors.lastname: Kunkel
authors.forename: S D
authors.initials: SD
authors.lastname: Miller
mesh_terms: D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D002490:Central Nervous System / Q000276:immunology / Q000378:metabolism; D018932:Chemokine CCL2 / Q000276:immunology*; D054407:Chemokine CCL4; D016207:Cytokines / Q000276:immunology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D019402:Macrophage Inflammatory Proteins; D051379:Mice; D015846:Monokines / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000906:Antibodies; D018932:Chemokine CCL2; D054407:Chemokine CCL4; D016207:Cytokines; D019402:Macrophage Inflammatory Proteins; D015846:Monokines